Invention Grant
- Patent Title: Nitrogen-containing heteroaryl compound and pharmaceutical use thereof
-
Application No.: US16150989Application Date: 2018-10-03
-
Publication No.: US10752596B2Publication Date: 2020-08-25
- Inventor: Hironobu Nagamori , Tatsuya Nishimaru , Masaki Takagi , Ikuo Mitani , Yuichi Nakagawa
- Applicant: JAPAN TOBACCO INC.
- Applicant Address: JP Tokyo
- Assignee: JAPAN TOBACCO INC.
- Current Assignee: JAPAN TOBACCO INC.
- Current Assignee Address: JP Tokyo
- Agency: Leydig, Voit & Mayer, Ltd.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@5bd3e892
- Main IPC: C07D241/12
- IPC: C07D241/12 ; C07D213/46 ; A61P19/06 ; C07D405/10 ; A61P43/00 ; A61K31/4965 ; C07D217/16 ; A61K31/497 ; C07D213/55 ; A61K31/4433 ; A61K31/4418 ; C07D405/04 ; A61K31/472
Abstract:
The invention provides a compound having a GLUT9 inhibitory activity. The compound is of Formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20190152926A1 NITROGEN-CONTAINING HETEROARYL COMPOUND AND PHARMACEUTICAL USE THEREOF Public/Granted day:2019-05-23
Information query
